Login / Signup

Efficacy of immune checkpoint inhibitors in different types of melanoma.

Ernesto RossiGiovanni SchinzariBrigida Anna MaioranoGiulia IndellicatiAlessandro Di StefaniMonica Maria PagliaraSimona Maria FragomeniErika Valentina De LucaMaria Grazia SammarcoGiorgia GarganeseJacopo GalliMaria Antonietta BlasiGaetano PaludettiGiovanni ScambiaKetty PerisGiampaolo Tortora
Published in: Human vaccines & immunotherapeutics (2020)
Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune checkpoint inhibitors in the various types of melanoma were reviewed.
Keyphrases
  • skin cancer
  • dna damage
  • cell cycle